Learn about JAX's collection of workhorse strains for tracking cells in adoptive transfer experiments, immunologically important cellular subsets, MHC Class I, II, and TCR-specific responses, & more.
Watch Video
Read Flipbook
Learn about Hu-PBMC NSG models that can be used to test the efficacy of human T cell immunomodulatory therapeutics for graft-versus-host disease (GvHD), autoimmune disorders, and cancer.
Watch Video
Read Flipbook
Watch this webinar to learn about Experimental Autoimmune Encephalomyelitis (EAE), which serves as the gold standard preclinical model for MS research.
Watch Video
Read Flipbook
Assessing efficacy and toxicity in CAR-T studies in an accessible translational model. The Jackson Laboratory's in vivo PBMC-humanized mouse platform provides a wider window to look at cytokine releas
Watch Video
Read Flipbook
Read Flipbook
Presented by Richard Stebbings, Ph.D., Senior Director Oncology Safety Science, AstraZeneca
Read Flipbook
Of mice and men - FcRn biology and its implications in a therapeutic perspective Presented by Jan Terje Andersen, Ph.D. - Professor in Biomedical Innovation, University of Oslo, Co-founder, Authera,
Watch Video
Preclinical Assessment of Engineered Immunoglobulins in Immune-humanized Mice Presented by Brian Soper, Ph.D. - Senior Scientific Engagement Manager, The Jackson Laboratory, Bar Harbor, USA Presen
Watch Video
In this webinar, we discuss upcoming and established strains in the JAX COVID-19 Model Portfolio, in the context of in vivo findings with SARS-CoV2 and related viruses.
Watch Video
March 1, 2022 - In this episode, the JAX Tech Talk Team welcomes Prabir Banerjee to discuss the JAX GvHD platform and its value in accelerating your preclinical research studies.
Watch Video
Veronika Weß leads an informative discussion on the use of the immune-humanized mouse platform to explore the biological underpinnings of inflammatory bowel disease (IBD).
Watch Video
Although many mammals have immune systems that share important characteristics with humans, certain immune cell types and phenomena are unique to us. As a result, it has been difficult to design...
Learn More
February 1, 2022 - With COVID-19 research ever-evolving and novel research results becoming available, Team JAX Tech Talk looks to discuss the newest advancements in the field.
Watch Video
October 5, 2021 - Is your treatment robust enough to "work" in different genetic backgrounds? Are your preclinical studies assessing translatability? In this episode, we will explore: how J:DO mice m
Watch Video
September 14, 2021 - In this episode, we discuss how the xenogeneic GvHD model in NSG mice aligns with your drug development pipeline.
Watch Video
An example of study information provided when conducting a GvHD study with the Jackson Laboratory. This example shows Bispecific Antibodies in comparison with Abatacept.
Read Flipbook
Loading More...
